NTHI

About NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Stock

NeOnc Technologies Holdings, Inc. Common Stock (NTHI) closed the 2026-09-18 session at $3.26, down 4.40% versus the previous close (-0.15). The stock opened at $3.63 and traded between $3.19 and $3.68 during that session. Session trading volume was 419K shares. The volume-weighted average price (VWAP) is $3.31.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

NeOnc Technologies Holdings, Inc. Common Stock has a market capitalization of $93.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. NTHI is listed on the XNAS exchange. The company employs approximately 5 people. NeOnc Technologies Holdings, Inc. Common Stock is headquartered in CALABASAS, CA. The recorded listing date is 2025-03-26.

On this page you can find market NTHI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.